July 26 (Reuters) – Eli Lilly and Co on Tuesday
reported better-than-expected quarterly sales, fueled by newer
drugs, and predicted average annual revenue growth of at least 5
percent through the end…
The post UPDATE 3-Lilly sales beat estimates, helped by newer drugs appeared first on NASDAQ.